WuXi Biologics Receives Jade Award for ESG Leadership

• WuXi Biologics received the top Jade Award at The Asset Corporate Sustainability Leadership Awards 2026, the only pharmaceutical company among recipients.
• The Best in Transition (Hong Kong) award recognized its progress in green manufacturing and digital transformation.
• Its Green CRDMO solutions embed sustainability across biologics development and manufacturing; a digital ESG platform supports monitoring and decision-making.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.